Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
Abiiomed: Lots Of Growth Ahead (NASDAQ:ABMD)
05:08pm, Monday, 06'th Jul 2020
The expanding market opportunity and superior financial metrics has me bullish on Abiomed. Even with an economic slowdown, I expect Abiomed to grow net profits by 15% annually due to the continued ado
ABIOMED, Inc. (NASDAQ:ABMD) Receives $186.40 Average PT from Analysts
08:22am, Monday, 06'th Jul 2020
ABIOMED, Inc. (NASDAQ:ABMD) has been assigned a consensus recommendation of “Hold” from the twelve brokerages that are presently covering the firm, Marketbeat reports. Two equities research analys
Comparing ABIOMED (NASDAQ:ABMD) & Titan Medical (NASDAQ:TMDI)
01:56am, Friday, 03'rd Jul 2020
Titan Medical (NASDAQ:TMDI) and ABIOMED (NASDAQ:ABMD) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability,
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings
01:00pm, Thursday, 02'nd Jul 2020
MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced the closing of concurr
Stay-at-home orders helped lift several Mass. stocks in the first half of 2020 - The Boston Globe
10:02am, Thursday, 02'nd Jul 2020
We are in a Work From Home World, and Wall Street knows it.
Axa Grows Stock Holdings in ABIOMED, Inc. (NASDAQ:ABMD)
06:20am, Thursday, 02'nd Jul 2020
Axa increased its stake in shares of ABIOMED, Inc. (NASDAQ:ABMD) by 16.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. Th
Laut der ersten in den USA veröffentlichten Studie von Patienten, die die neueste Herzpumpe von Abiomed, die Impella 5.5 mit SmartAssist, erhalten hab
The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist, finds 84% of the patients survived to explant with 76% native heart r
These stocks, including Tesla and Apple, are the real winners for the second quarter of 2020
10:24am, Wednesday, 01'st Jul 2020
A select group of stocks rose in the second quarter and for all of 2020.
The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist, finds 84% of the pati
Goldman Says Tech Valuations to Remain Intact if Rates Go Higher
12:00am, Tuesday, 30'th Jun 2020
Goldman Says Tech Valuations to Remain Intact if Rates Go Higher
